Prepectoral Direct-to-Implant Breast Reconstruction: Safety Outcome Endpoints and Delineation of Risk Factors.

Plastic and reconstructive surgery 2020 Vol.145(5) p. 898e-908e

Nealon KP, Weitzman RE, Sobti N, Gadd M, Specht M, Jimenez RB, Ehrlichman R, Faulkner HR, Austen WG, Liao EC

관련 도메인

Abstract

[BACKGROUND] Continued evolution of implant-based breast reconstruction involves immediate placement of the implant above the pectoralis muscle. The shift to prepectoral breast reconstruction is driven by goals of decreasing morbidity such as breast animation deformity, range-of-motion problems, and pain, and is made possible by improvements in mastectomy skin flap viability. To define clinical factors to guide patient selection for direct-to-implant prepectoral implant reconstruction, this study compares safety endpoints and risk factors between prepectoral and subpectoral direct-to-implant breast reconstruction cohorts. The authors hypothesized that prepectoral direct-to-implant breast reconstruction is a safe alternative to subpectoral direct-to-implant breast reconstruction.

[METHODS] Retrospective chart review identified patients who underwent prepectoral and subpectoral direct-to-implant breast reconstruction, performed by a team of five surgical oncologists and two plastic surgeons. Univariate analysis compared patient characteristics between cohorts. A penalized logistic regression model was constructed to identify relationships between postoperative complications and covariate risk factors.

[RESULTS] A cohort of 114 prepectoral direct-to-implant patients was compared with 142 subpectoral direct-to-implant patients. The results of the penalized regression model demonstrated equivalence in safety metrics between prepectoral direct-to-implant and subpectoral direct-to-implant breast reconstruction, including seroma (p = 0.0883), cancer recurrence (p = 0.876), explantation (p = 0.992), capsular contracture (p = 0.158), mastectomy skin flap necrosis (p = 0.769), infection (p = 0.523), hematoma (p = 0.228), and revision (p = 0.122).

[CONCLUSIONS] This study demonstrates that prepectoral direct-to-implant reconstruction is a safe alternative to subpectoral direct-to-implant reconstruction. Given the low morbidity and elimination of animation deformity, prepectoral direct-to-implant reconstruction should be considered when the mastectomy skin flap is robust.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, III.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 9
기법 subpectoral 근막하 평면 dict 6
시술 flap 피판재건술 dict 3
해부 Prepectoral scispacy 1
해부 pectoralis muscle scispacy 1
합병증 prepectoral breast scispacy 1
합병증 hematoma 혈종 dict 1
합병증 seroma 장액종 dict 1
합병증 infection 감염 dict 1
합병증 flap necrosis 괴사 dict 1
합병증 capsular contracture 피막구축 dict 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] A scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Prepectoral Direct-to-Implant Breast scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 necrosis C0027540
Necrosis
scispacy 1
기타 skin flap scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1

MeSH Terms

Acellular Dermis; Adult; Breast; Breast Implantation; Breast Neoplasms; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pectoralis Muscles; Postoperative Complications; Retrospective Studies; Risk Factors; Surgical Flaps; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문